NAD+ Boosters: What Human Trials Show
NAD+ precursors (NMN, NR) and IV NAD+ vs the human evidence: blood levels rise, functional results are mixed, IV NAD+ has no anti-aging outcome trials.
Researched from published studies and manufacturer specifications, checked .
We have not tested products ourselves. How we research
Quick verdict
Oral NMN and NR reliably raise NAD-related levels in blood and are generally well tolerated, but a 2026 review of 33 human studies found functional and healthspan outcomes heterogeneous and often null. It found no outcome trials of IV NAD+ for anti-aging. Effectiveness for anti-aging is unproven.
Talk to your doctor first. This is general information, not medical advice. Supplements and devices can interact with medicines and health conditions. We quote study protocols for context and do not recommend doses.
The short answer: oral NMN and NR reliably raise NAD-related levels in blood and are generally well tolerated over weeks to months, but a 2026 systematic review of 33 human studies found that effects on function, metabolism and other health outcomes were heterogeneous and often null. It found no outcome trials of IV NAD+ for anti-aging or wellness. Whether boosting NAD+ improves human health is unproven. Talk to your doctor before starting.
What the evidence shows
Grades follow the rubric; overall grade for oral precursors: Emerging.
| Question | Grade | Evidence | Limit |
|---|---|---|---|
| Raise NAD-related blood levels (oral NMN or NR) | Moderate | The 2026 systematic review: consistent target engagement | A biomarker, not a health outcome |
| Muscle mass and function in adults over 60 | Weak | A 2025 meta-analysis: current evidence does not support NMN or NR for preserving muscle mass and function | Small trials |
| Insulin sensitivity | Mixed | NMN improved muscle insulin sensitivity in postmenopausal women with prediabetes (Science 2021); NR did not change glucose tolerance in men with obesity (2019) | Different populations, precursors and doses |
| IV NAD+ for anti-aging | Not shown | The 2026 review found no eligible outcome trials | No outcome data |
The trial-by-trial NMN and NR comparison, current US legal status of NMN and cost per study dose are on the NMN page. The head-to-head summary is at NMN vs NR.
Where it fits
NAD+ precursors sit near the bottom of the graded supplement ladder by strength of human evidence, and are not cheap at the doses trials used. For habits with better evidence, see zone 2 training, strength training and sleep. Related: resveratrol and pterostilbene, the complete stack and the NMN database card. Product pages: Tru Niagen (NR), NMN on Amazon; we may earn a commission from these Amazon links.
Method note
Read for this page: NAD+ supplementation for anti-aging and wellness, PRISMA-guided systematic review (Ageing Res Rev 2026); NMN and NR for muscle mass and function, systematic review and meta-analysis (J Cachexia Sarcopenia Muscle 2025); NMN in postmenopausal women with prediabetes (Science 2021), and 1 more listed above. Checked 29 Sept 2026. Abstracts only; grades are our judgement using the published rubric. We did not test any product. General information, not medical advice: this page gives no dosing guidance.
Common questions
Do NAD+ boosters work?
They change the biochemistry: a 2026 systematic review of 33 human intervention studies found oral NR and NMN consistently raised NAD-related metabolites and were generally well tolerated. Effects on functional, metabolic and vascular outcomes were heterogeneous and often null, and the review called clinical effectiveness for anti-aging inconclusive.
What about NAD+ IV drips?
The same 2026 review found no eligible outcome trials of intravenous or intramuscular NAD+ itself for anti-aging or wellness. One non-randomised IV NMN study contributed short-term safety and biomarker information only.
Sources
- NAD+ supplementation for anti-aging and wellness, PRISMA-guided systematic review (Ageing Res Rev 2026) checked 29 Sept 2026
- NMN and NR for muscle mass and function, systematic review and meta-analysis (J Cachexia Sarcopenia Muscle 2025) checked 29 Sept 2026
- NMN in postmenopausal women with prediabetes (Science 2021) checked 29 Sept 2026
- NR in men with obesity (J Clin Endocrinol Metab 2019) checked 29 Sept 2026
Update log
- Sourcing pass: removed the unsourced 50% decline figure, the five-pathway and CD38 sections, dosing protocol and stacking advice; replaced with the 2026 systematic review and trial results. NMN regulatory status and trial detail live on the NMN page.
Data and comparisons
- NR evidence record
An alternative NAD+ precursor with more human trial data than NMN
- NMN evidence record
A direct NAD+ precursor that restores declining NAD+ levels with age
- Resveratrol evidence record
A polyphenol that activates sirtuins (SIRT1)
- TMG evidence record
A methyl donor that counteracts the methylation depletion caused by NMN/NR supplementation
- NMN vs NR: Which NAD+ precursor is better?
No head-to-head trial; both raise blood NAD+, outcomes mixed
Related reading
NMN: Legal Status, NMN vs NR, What Trials Show
Is NMN legal in the US supplement market, how does it compare with NR, what human trials found, and what a month costs at the dose those trials used.
CoQ10 and Ubiquinol: What Trials Show, and Cost
CoQ10 evidence: Q-SYMBIO in heart failure patients, mixed statin-muscle-pain meta-analyses, ubiquinol vs ubiquinone, and monthly cost at the trial dose.
Omega-3 Fish Oil: What Trials Show, Cost per EPA+DHA
Omega-3 fish oil from the big trials: VITAL, REDUCE-IT and STRENGTH results, the atrial fibrillation signal, and monthly cost at the dose VITAL used.
Quercetin and Fisetin: Senolytic Claims vs Trials
Quercetin and fisetin as senolytics: human trials tested dasatinib plus quercetin in patients, not supplements for healthy aging.